ZA972944B - Novel retinoids. - Google Patents

Novel retinoids.

Info

Publication number
ZA972944B
ZA972944B ZA9702944A ZA972944A ZA972944B ZA 972944 B ZA972944 B ZA 972944B ZA 9702944 A ZA9702944 A ZA 9702944A ZA 972944 A ZA972944 A ZA 972944A ZA 972944 B ZA972944 B ZA 972944B
Authority
ZA
South Africa
Prior art keywords
novel retinoids
retinoids
novel
Prior art date
Application number
ZA9702944A
Other languages
English (en)
Inventor
Michael Klaus
Peter Mohr
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of ZA972944B publication Critical patent/ZA972944B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C403/00—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone
    • C07C403/20—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone having side-chains substituted by carboxyl groups or halides, anhydrides, or (thio)esters thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
    • C07C59/62—Unsaturated compounds containing ether groups, groups, groups, or groups containing rings other than six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
    • C07C69/732—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids of unsaturated hydroxy carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/09—Geometrical isomers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/16—Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA9702944A 1996-04-15 1997-04-07 Novel retinoids. ZA972944B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP96105849 1996-04-15

Publications (1)

Publication Number Publication Date
ZA972944B true ZA972944B (en) 1997-10-15

Family

ID=8222666

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9702944A ZA972944B (en) 1996-04-15 1997-04-07 Novel retinoids.

Country Status (28)

Country Link
US (1) US5990329A (da)
JP (1) JP2801589B2 (da)
KR (1) KR100240542B1 (da)
CN (1) CN1116270C (da)
AR (1) AR006632A1 (da)
AT (1) ATE187962T1 (da)
AU (1) AU715816B2 (da)
BR (1) BR9701790A (da)
CA (1) CA2202228C (da)
CO (1) CO4890844A1 (da)
CZ (1) CZ113397A3 (da)
DE (1) DE59700872D1 (da)
DK (1) DK0802181T3 (da)
ES (1) ES2141556T3 (da)
HR (1) HRP970204B1 (da)
HU (1) HU220112B (da)
IL (1) IL120637A (da)
MA (1) MA24142A1 (da)
NO (1) NO308842B1 (da)
NZ (1) NZ314525A (da)
PE (1) PE42498A1 (da)
PL (1) PL319477A1 (da)
PT (1) PT802181E (da)
SG (1) SG52949A1 (da)
TR (1) TR199700297A2 (da)
TW (1) TW442459B (da)
YU (1) YU14997A (da)
ZA (1) ZA972944B (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL142094A0 (en) 1998-09-29 2002-03-10 Gamida Cell Ltd Methods of controlling proliferation and differentiation of stem and progenitor cells
IL152904A0 (en) 2002-01-24 2003-06-24 Gamida Cell Ltd Utilization of retinoid and vitamin d receptor antagonists for expansion of renewable stem cell populations
EP1465982A4 (en) 2002-01-25 2006-06-07 Gamida Cell Ltd PROCESS FOR EXPANSION OF STEM AND PRESERVATIVE CELLS AND EXPANDED CELL POPULATIONS THEREWITH OBTAINED
WO2006030442A2 (en) 2004-09-16 2006-03-23 Gamida-Cell Ltd. Methods of ex vivo progenitor and stem cell expansion by co-culture with mesenchymal cells
US8846393B2 (en) 2005-11-29 2014-09-30 Gamida-Cell Ltd. Methods of improving stem cell homing and engraftment
WO2013121426A1 (en) 2012-02-13 2013-08-22 Gamida-Cell Ltd. Culturing of mesenchymal stem cells
US9567569B2 (en) 2012-07-23 2017-02-14 Gamida Cell Ltd. Methods of culturing and expanding mesenchymal stem cells
US9175266B2 (en) 2012-07-23 2015-11-03 Gamida Cell Ltd. Enhancement of natural killer (NK) cell proliferation and activity

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4169103A (en) * 1978-04-12 1979-09-25 Hoffmann-La Roche Inc. Nonatetraenoic acid derivatives
DE2843901A1 (de) * 1978-10-07 1980-04-24 Basf Ag Mittel, enthaltend all-e- oder 13-z-7, 8-dehydro-retinsaeure
CH658387A5 (de) * 1984-04-02 1986-11-14 Hoffmann La Roche Pharmazeutische praeparate.
CZ282548B6 (cs) * 1992-01-22 1997-08-13 F. Hoffmann-La Roche Ag Farmaceutický přípravek

Also Published As

Publication number Publication date
NO971711D0 (no) 1997-04-14
JPH1036343A (ja) 1998-02-10
AU715816B2 (en) 2000-02-10
ATE187962T1 (de) 2000-01-15
MA24142A1 (fr) 1997-12-31
JP2801589B2 (ja) 1998-09-21
CN1116270C (zh) 2003-07-30
AU1772697A (en) 1997-10-23
HK1003054A1 (en) 1998-10-09
NO308842B1 (no) 2000-11-06
CA2202228A1 (en) 1997-10-15
HU9700747D0 (en) 1997-05-28
AR006632A1 (es) 1999-09-08
NZ314525A (en) 1998-02-26
TR199700297A2 (xx) 1997-11-21
US5990329A (en) 1999-11-23
HUP9700747A3 (en) 1998-04-28
CN1167752A (zh) 1997-12-17
SG52949A1 (en) 1998-09-28
YU14997A (sh) 1999-09-27
TW442459B (en) 2001-06-23
HU220112B (hu) 2001-11-28
IL120637A0 (en) 1997-08-14
NO971711L (no) 1997-10-16
CO4890844A1 (es) 2000-02-28
CZ113397A3 (cs) 1998-02-18
DE59700872D1 (de) 2000-01-27
HUP9700747A1 (en) 1997-12-29
CA2202228C (en) 2007-03-06
PL319477A1 (en) 1997-10-27
HRP970204A2 (en) 1998-04-30
HRP970204B1 (en) 2000-10-31
MX9702697A (es) 1997-10-31
BR9701790A (pt) 1998-11-10
DK0802181T3 (da) 2000-04-17
KR970069969A (ko) 1997-11-07
PE42498A1 (es) 1998-08-18
IL120637A (en) 2000-11-21
KR100240542B1 (ko) 2000-01-15
PT802181E (pt) 2000-05-31
ES2141556T3 (es) 2000-03-16

Similar Documents

Publication Publication Date Title
ZA9710429B (en) Broad-spectrumδ-endotoxins.
ZA979199B (en) Aminothiophenecarboxamides.
ZA976168B (en) 3-Ureido-pyridofurans and -pyridothiophenes.
ZA977206B (en) Arylalkanoylpyridazines.
ZA978304B (en) 3-alkyl-3-phenyl-piperidines.
EP0664969A3 (de) Skischuh.
DE69723848D1 (en) 3-descladinose-2,3-anhydroerythromycin-derivate
DE69610844D1 (en) Hydroformylierungsverfahren.
ZA97572B (en) 1-pyrazol-3-ylethyl-4-indol-3-ylpiperidines.
ZA97928B (en) Novel heteroaryl-oxazolidinones.
ZA963540B (en) Tetralines.
ZA966399B (en) Endothelin-receptor-antagonists.
SG52949A1 (en) Novel retinoids
ZA974052B (en) New benzothiazolinones.
ZA976022B (en) Cycloalkano-pyridines.
ZA971466B (en) Endothelin-receptor-antagonists.
EP0672364A3 (de) Skischuh.
ZA974056B (en) New thiazolopyridines.
GR3034943T3 (en) Medrogestrone.
EP0671133A3 (de) Skischuh.
ZA971474B (en) Endothelin-receptor-antagonists.
ZA969560B (en) Substituted 1-methyl-3-phenylpyrazoles.
ZA975469B (en) X14-mannitol.
ZA977142B (en) Belt-lock.
ZA9710102B (en) Novel benzonaphthyridines.